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Abstract
Background: Bone mineral density is known to decrease rapidly after the menopause. There is limited evidence about the
separate contributions of a woman’s age, menopausal status and age at menopause to the incidence of hip fracture.
Methods and Findings: Over one million middle-aged women joined the UK Million Women Study in 1996–2001 providing
information on their menopausal status, age at menopause, and other factors, which was updated, where possible, 3 y later.
All women were registered with the UK National Health Service (NHS) and were routinely linked to information on cause-
specific admissions to NHS hospitals. 561,609 women who had never used hormone replacement therapy and who
provided complete information on menopausal variables (at baseline 25% were pre/perimenopausal and 75%
postmenopausal) were followed up for a total of 3.4 million woman-years (an average 6.2 y per woman). During follow-
up 1,676 (0.3%) were admitted to hospital with a first incident hip fracture. Among women aged 50–54 y the relative risk
(RR) of hip fracture risk was significantly higher in postmenopausal than premenopausal women (adjusted RR 2.22, 95%
confidence interval [CI] 1.22–4.04; p= 0.009); there were too few premenopausal women aged 55 y and over for valid
comparisons. Among postmenopausal women, hip fracture incidence increased steeply with age (p,0.001), with rates
being about seven times higher at age 70–74 y than at 50–54 y (incidence rates of 0.82 versus 0.11 per 100 women over
5 y). Among postmenopausal women of a given age there was no significant difference in hip fracture incidence between
women whose menopause was due to bilateral oophorectomy compared to a natural menopause (adjusted RR 1.20, 95% CI
0.94–1.55; p= 0.15), and age at menopause had little, if any, effect on hip fracture incidence.
Conclusions: At around the time of the menopause, hip fracture incidence is about twice as high in postmenopausal than in
premenopausal women, but this effect is short lived. Among postmenopausal women, age is by far the main determinant of
hip fracture incidence and, for women of a given age, their age at menopause has, at most, a weak additional effect.
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Introduction
As women age, hip fractures become an increasingly important
cause of morbidity and mortality. Reduced bone mineral density
is a key risk factor for hip fracture [1]. Bone density is known to
decrease rapidly in the period immediately after the menopause
and more slowly thereafter [2–4]. Although early menopause is
widely considered to be a risk factor for osteoporosis and fracture
in later life [5], there is limited evidence about how menopause
influences hip fracture risk as women grow older, and uncertainty
around whether an earlier menopause leads to a lasting increase
in risk [6,7]. Previous studies have generally not found a
significant effect of younger age at menopause on hip fracture
risk [6,8–19], although many of these studies were small and
had limited ability to account for potential confounding factors.
This study describes the incidence of hip fracture in relation
to age, menopausal status, and age at menopause in a large cohort
of UK women who have never used hormone replacement
therapy.
Materials and Methods
Ethics Statement
The study has been approved by the Eastern Multi-centre
Research Ethics Committee and all study participants provided
written consent to take part.
Data Collection and Definitions
The Million Women Study is a large national prospective study
that recruited 1.3 million middle-aged women from National
Health Service (NHS) breast screening clinics in England and
Scotland in 1996–2001; its methods are described elsewhere [20].
Participants provided information on sociodemographic and
anthropometric factors, menopausal status, use of hormone
replacement therapy, and medical and reproductive history by
filling in a questionnaire at recruitment. The study population was
resurveyed in 1999–2004, about 3 y after recruitment, with a
response rate of 65%. Study questionnaires can be viewed at www.
millionwomenstudy.org.uk.
All study participants were registered with the NHS at
recruitment. Their unique NHS personal identifying number is
used for all NHS health records, including those relating to the
breast cancer screening programme and hospital admissions. All
study participants have been linked electronically using their
unique NHS number and other personal details, to obtain
information on NHS hospital admissions, cancer registrations,
deaths, and emigrations. The hospital data include details of
hospital admissions in study participants in Scotland from 1st
January 1981 to the 31st of December 2003 [21] and in England
from 1st April 1997 to the 31st of March 2005 [22]. For every
hospital episode the date of admission is recorded, as is the
primary reason for admission, with up to 13 additional clinical
diagnoses coded using the World Health Organisation Interna-
tional Classification of Diseases 9th and 10th revisions (ICD-9 and
ICD-10) [23]. As well, up to 12 operations or procedures are
coded for each hospital episode using the Office of Population
Censuses and Surveys Classification of Surgical Operations and
Procedures, 3rd and 4th revisions (OPCS-3 and OPCS-4) [24].
Analysis
For these analyses the main outcome, hip fracture, is defined as
the first hospitalisation following recruitment into the Million
Women Study with a final primary diagnosis of fractured neck of
femur at discharge (ICD-10 codes S72.0–S72.2 and S72.9).
Analyses are restricted to women reporting at recruitment that
they had never used hormone replacement therapy, since use of
hormone replacement therapy is closely related to a woman’s
menopausal status and her age at menopause [25] and has a
substantial impact on the risk of fracture [26,27]. Of the 659,737
women reporting at recruitment that they had never used
hormone replacement therapy, 25,218 (3.8%) who had a cancer
registered prior to recruitment, other than nonmelanoma skin
cancer (ICD10 C44), were excluded because a substantial
proportion of cancers in women, and their treatments, relate to
hormonal factors and a previous diagnosis of cancer is likely to
influence the risk of hip fracture. A further 68,551 women who
had an unknown age at menopause because of having had a
hysterectomy without bilateral oophorectomy prior to natural
menopause, and 4,359 who were missing data on menopausal
status, were also excluded leaving 561,609 women for the main
analyses.
Woman-years were calculated from the date of recruitment up
to the date of first hospital admission for the hip fracture, date of
death, date of emigration, or the end of follow-up, whichever came
first. For women recruited in Scotland the last date of follow-up
was the 31st of December 2003 and for those in England the last
date was the 31st of March 2005, corresponding to the dates after
which the hospital records were still incomplete at the time of
record-linkage. Woman-years were calculated from 1st April 1997
for the small proportion of women (5%) recruited in England
before that date, as hospital admission data were not available
before then. Menopausal status and age at menopause were
classified initially using information provided at recruitment, and
were reclassified whenever possible using updated information on
menopause reported at resurvey, as described previously [28,29].
For 226 (13%) out of 1,676 women with a first incident hip
fracture, self-reported information on the cause of the hip fracture
was available from the follow-up questionnaire.
Premenopausal women were defined as those who reported
having regular menstrual periods, perimenopausal women were
those who reported that their periods were irregular because of the
menopause, and postmenopausal women were those reporting
cessation of their periods, as the result of natural menopause or a
bilateral oophorectomy. These baseline measures were checked
against follow-up data obtained approximately 3 y later. Of
47,859 women classified as perimenopausal at recruitment, 19.6%
(9,386) were perimenopausal and 77.5% (37,066) were postmen-
opausal at follow-up. In contrast, of 40,495 women who were
classified as premenopausal at recruitment, 28.2% (11,423) were
premenopausal, 32.9% (13,337) were perimenopausal, and 38.9%
(15,735) were postmenopausal at follow-up. This finding suggests
that our definitions are predictive of the timing of the menopausal
transition. Data from premenopausal and perimenopausal women
were censored 48 mo after baseline if they reported being pre- or
perimenopausal at follow-up or did not return a follow-up form, as
their status is likely to have altered subsequently.
Relative risks (RRs) for hip fracture according to menopausal
status and age at menopause were estimated using a Cox regression
model, in which the underlying time variable was the woman’s age.
RRs and 95% confidence intervals (CIs) take account of age (the
underlying time variable) and region and were adjusted further for:
socioeconomic status (in quintiles, measured by Townsend score,
which is based on car and home ownership, overcrowding, and
unemployment in the area of residence [30]); body mass index
(,22.5, 22.5–24.9, 25.0–27.4, 27.5–29.9, $30 kg/m2); cigarette
smoking (current, past, never); alcohol consumption (never,,1,$1
drinks per week); strenuous physical activity (,1, $1 time per
week); parity (nulliparous, parous); previous use of oral contracep-
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tives (ever, never); and medical history (history of heart disease/
stroke/thrombosis, diabetes mellitus, thyroid disease, rheumatoid
arthritis, and osteoarthritis). Results were unchanged following
adjustment for finer categories of alcohol consumption and
strenuous physical activity; the broader categories were therefore
retained. The RR of hip fracture in postmenopausal women who
had menopause resulting from a bilateral oophorectomy compared
to those with a natural menopause was adjusted for all of the factors
mentioned above, as well as age at menopause. The proportional
hazards assumption was tested using Schoenfeld residuals. Sensi-
tivity analyses were conducted examining the effect on the exposure
of interest of stratifying by adjustment variables showing non-
proportionality and of excluding women with a hip fracture
recorded prior to recruitment. The STATA 10.1 computing
package was used for all analyses [31].
Results
The characteristics of the study population are presented in
Table 1 according to menopausal status and age at menopause,
at recruitment. Of the 561,609 never users of hormone
replacement therapy included in the analyses, 25% were pre/
perimenopausal and 75% were postmenopausal at recruitment
and, as expected, pre/perimenopausal women at recruitment
were younger than the postmenopausal women (mean age 51 y
versus 58 y). Various differences in the characteristics of the pre/
perimenopausal and postmenopausal women largely reflect their
younger age. Among the postmenopausal women 11% reported
that their menopause had occurred before age 45 and 61%
reported that their menopause had occurred at age 50 y or older.
Women with an early menopause (before age 45 y) differed
substantially from women with a later menopause (at 50 y or
later)—as well as being more likely to have had a bilateral
oophorectomy they were more likely to be of lower socioeco-
nomic status, more likely to smoke, and more likely to have a
history of heart disease, stroke, thrombosis, diabetes, thyroid
disease, and arthritis (p,0.001).
The study population was followed for a total of 3,350,662
woman-years; an average of 6.2 y per woman. During follow-up
1,676 (0.3%) women were admitted to hospital with a first incident
hip fracture, on average, 3.7 y after recruitment. Of the women
with a hip fracture who had self-reported data on the cause of the
hip fracture, 88% (199/226) were the result of a fall, 1% (2/226)
the result of a motor vehicle accident, 1% (3/226) due to some
other accident, 5% (11/226) occurred in some other way, and 5%
(11/226) did not specify a cause.
Menopausal Status
Since most women become menopausal in their late 40s and
early 50s, there is limited scope for comparing the incidence of hip
fracture by menopausal status in women of a given age. So that we
could directly examine the effect of menopausal status in groups of
women of similar age we restricted analyses to women within a
narrow age range from 50 to 54 y. In these analyses participants
contributed woman-years only up to the day they turned 55, and
were censored thereafter. For women aged 50–54 y, the RR of hip
fracture in postmenopausal women was more than double that in
premenopausal women of a similar age (adjusted RR 2.22, 95%
Table 1. Characteristics of study population (never users of hormone replacement therapy) according to menopausal status at
recruitment and age at menopause.
Study Population Pre/Perimenopausal Age (y) at Menopause among Postmenopausal Women All Postmenopausal
,45 45–49 50+
Number of women 141,886 49,132 124,342 233,505 419,723
Characteristics at recruitment
Age (mean [SD], y) 51.2 [1.9] 58.4 [4.6] 57.1 [4.9] 58.5 [4.2] 58.1 [4.5]
Bilateral oophorectomy (% [n]) 0% [0] 11% [5,334] 2% [2,938] 1% [2,538] 3% [11,299]
Socioeconomic status (% [n] in lower third) 29% [40,970] 43% [21,032] 37% [45,873] 32% [73,962] 35% [145,950]
Parity (% [n] with parity $2) 75% [106,382] 69% [33,889] 71% [88,779] 74% [173,904] 73% [305,269]
Past use of oral contraceptives (% [n]) 69% [98,508] 43% [21,358] 48% [59,709] 42% [98,292] 44% [184,034]
Current smoker (% [n]) 14% [19,333] 29% [14,364] 24% [29,330] 14% [33,191] 19% [79,413]
Alcohol consumption (mean [SD], g/week) 46.5 [55.4] 32.2 [48.6] 35.6 [50.0] 35.9 [49.2] 35.2 [49.4]
Body-mass index (mean [SD], kg/m2) 26.2 [5.0] 26.5 [5.1] 26.2 [4.8] 26.5 [4.8] 26.4 [4.9]
Strenuous physical activity (% [n] more
than once/week)
41% [57,933] 31% [15,002] 35% [43,333] 38% [88,848] 36% [151,062]
History of heart disease, stroke or
thrombosis (% [n])
5% [7,496] 15% [7,150] 10% [12,525] 10% [22,569] 10% [43,796]
History of diabetes mellitus (% [n]) 2% [2,631] 4% [2,175] 3% [4,024] 3% [8,017] 4% [14,884]
History of thyroid disease (% [n]) 4% [6,065] 7% [3,480] 6% [7,383] 6% [13,541] 6% [25,272]
History of rheumatoid arthritis (% [n]) 2% [3,040] 7% [3,507] 5% [6,064] 4% [9,713] 5% [20,092]
History of osteoarthritis (% [n]) 4% [5,375] 10% [4,727] 7% [9,266] 7% [17,428] 8% [32,450]
Follow-up for hip fracture
Woman-years of follow-up 769,522 297,985 763,512 1,441,796 2,581,140
First hospital admission for hip fracture (n) 86 252 464 801 1590
Women with missing values are not included. SD, standard deviation.
doi:10.1371/journal.pmed.1000181.t001
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CI 1.22–4.04, p = 0.009; Table 2). Excluding the 42 women aged
50–54 y with a hip fracture recorded prior to recruitment into the
study, findings were unchanged (adjusted RR 2.22 [1.22–4.04] in
premenopausal women, compared to postmenopausal women).
The risk of hip fracture in premenopausal and perimenopausal
women aged 50–54 y did not differ significantly (Table 2),
however the relatively wide CI means that a substantial increase
in the RR of hip fracture in perimenopausal compared to
premenopausal women cannot be excluded reliably. Figure 1
shows the age-specific incidence of hip fracture for pre/
perimenopausal women and postmenopausal women.
Effect of Age among Postmenopausal Women
Among postmenopausal women, the incidence of hip fracture
increased substantially with age, such that incidence rates were
about seven times higher at age 70–74 than 50–54 (Figure 2).
Incidence rates per 100 women over 5 y were 0.11, 0.15, 0.29,
0.48, and 0.82, respectively, at ages 50–54, 55–59, 60–64, 65–69,
and 70–74 (test for trend, p,0.001).
Type of and Age at Menopause among Postmenopausal
Women
Among postmenopausal women, the RR of hip fracture did not
vary significantly according to whether menopause occurred
naturally or as the result of a bilateral oophorectomy (adjusted
RR for bilateral oophorectomy versus natural menopause is 1.20,
95% CI 0.94–1.55; p = 0.15), however this CI is fairly wide and a
small differential effect of bilateral oophorectomy on hip fracture
cannot be ruled out.
Among postmenopausal women, there is, at most, a weak effect
of age at menopause on the risk of hip fracture (Table 3).
Adjustment for socioeconomic group, smoking, and other factors,
including medical history, substantially reduced the RR estimates
that were adjusted by age and region only (from 1.52 to 1.22 for
menopause before 45 y, and from 1.23 to 1.08 for menopause at
age 45–49 y, compared to 50 y and over, Table 3). The
corresponding x2 value declined by 80% or more, from 30.7 to
6.1 for menopause aged ,45 y and from 11.8 to 1.6 for
menopause at 45–49 y, compared to menopause at $50 y. Since
most of the factors adjusted for are measured with some error, and
adjustment for them reduced the x2 by 80% or more, adjustment
for their true values would be expected to reduce the x2 to an even
greater extent. This result suggests that there may well be residual
confounding in the adjusted estimate.
The RRs for the effect of menopausal status and age at
menopause on hip fracture conformed to the proportional hazards
assumption. These RRs changed by ,5% following stratifi-
cation for adjustment variables demonstrating nonproportionality,
namely BMI, cardiovascular disease, and arthritis. Hence, the
original models were retained.
Table 2. Hip fracture incidence and RR of hip fracture by
menopausal status among women aged 50–54 y who never
used hormone replacement therapy.
Menopausal Status
Hip Fracture Incidence per
100 Women over 5 y [n] RRa RRb (95% CI)
Premenopausal 0.03 [14] 1.00 1.00
Perimenopausal 0.05 [21] 1.30 1.25 (0.63–2.46)
Postmenopausal 0.11 [63] 2.83 2.22 (1.22–4.04)
Data are censored at age 55.
aAdjusted for age and region only.
bAdjusted for age, region, socioeconomic status, body-mass index, cigarette
smoking, alcohol consumption, physical activity, oral contraceptive use, parity,
and medical history.
doi:10.1371/journal.pmed.1000181.t002
Figure 1. Age-specific incidence of hip fracture in the study population who have never used hormone replacement therapy,
according to menopausal status.
doi:10.1371/journal.pmed.1000181.g001
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Discussion
This study shows that of the factors considered here, the main
determinants of the incidence of hip fracture are age and
menopausal status. At around the time of menopause, when women
are aged 50–54 y, the incidence of hip fracture was significantly
higher in postmenopausal than in premenopausal women. There
are too few premenopausal women aged 55 y and older to permit
valid comparison. Previous publications directly observing the
relationship between hip fracture risk in relation to menopause
generally involve older, postmenopausal women [6,9–14], and we
were unable to locate any publications comparing hip fracture rates
between premenopausal and postmenopausal women of a similar
age. The rapid and substantial impact of menopause on the risk of
hip fracture is likely to relate to the large reductions in bone mineral
density that occur in the first few years after the menopause [2–4],
which follow the rapid reductions in circulating levels of estradiol
and related hormones occurring at that time. This finding is in
keeping with the established protective effect of both endogenous
[32] and exogenous estrogens on fracture incidence [26,27].
In postmenopausal women the incidence of hip fracture
increases rapidly with age, with incidence rates in women
aged 70–74 y being about seven times higher than at 50–54
(Figure 2). The fact that hip fracture incidence increases rapidly
Figure 2. Age-specific incidence of hip fracture in postmenopausal women in the study population who have never used hormone
replacement therapy.
doi:10.1371/journal.pmed.1000181.g002
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with age in middle-aged and older women is well established
[9,10,12].
Our finding of no significant difference in hip fracture incidence
between postmenopausal women whose menopause resulted from
a bilateral oophorectomy compared to a natural menopause, after
adjusting for age and other relevant factors, is consistent with the
published findings from other studies [33,34], however the
relatively wide CI means that a small effect on risk remains
possible.
We found that women’s age at menopause had, at most, a weak
effect on the risk of hip fracture in postmenopausal women of a
given age. Women who had a menopause before age 45 differ
from those with a later menopause in many important respects;
they are more likely to have a history of various illnesses as well as
being more likely to smoke and to come from the lower
socioeconomic groups. Statistical adjustment for medical history,
as well as smoking and socioeconomic group, substantially reduced
the RR estimates for a menopause before age 45 versus at age 50
or older that were adjusted by age and region only (from 1.5 to
1.2), suggesting that these are important confounding factors. Our
findings are in keeping with previous studies that have shown that
the vast majority of hip fractures are the result of a fall [35–37]. No
information was collected on some other risk factors for hip
fracture, including previous falls and sensory impairment and
there was limited information on previous fractures. This lack of
information and the fact that the variables that were adjusted for
are measured with some error makes it likely that there is residual
confounding in the adjusted estimate.
Despite the widespread belief that early menopause is a long
term risk factor for osteoporosis and fracture [5], the published
evidence is in keeping with our finding of little, if any, effect of age
at menopause on the risk of hip fracture in postmenopausal
women, over and above the strong effect of women’s actual age.
We reviewed published results from studies with relevant
information on age at menopause and the risk of hip fracture.
Eligible studies that included at least 50 cases were identified
through PubMed and the Web of Science, using search terms
incorporating ‘‘menopause’’ and ‘‘fracture,’’ through searches for
articles citing a well known article on menopause and hip fracture
[9], and through hand searches of reference lists of identified
articles. Results were collated and, where possible, were
summarised as the adjusted RR and 95% CI for hip fracture in
women aged,45 y at menopause, compared to women aged 45 y
or older at menopause. A total of 12 eligible studies were
identified, varying in size from 56 [8] to 2,086 [13] hip fracture
cases [6,8–18]. Studies differed in their adjustment for age,
socioeconomic factors, use of hormone replacement therapy,
smoking, reproductive factors, body mass index, physical activity,
and mental status, and only two studies adjusted for comorbidity
[6,10]. Among the studies with relevant information, the estimated
RR for hip fracture in women with menopause aged ,45 y versus
45 y or older ranged from 1.02 to 1.30 [9,10,13,14], with no
studies reporting a significant difference. These point estimates are
consistent with the findings of the current study.
Data on bone mineral density suggest that once women are
postmenopausal, the age at which they become postmenopausal
has only a small effect, which is in keeping with our and other
findings regarding the effect of age at menopause and hip fracture
incidence. Previous studies have shown that bone mineral density
falls most rapidly in the immediate perimenopausal period and less
rapidly postmenopausally [2–4], with the rate of bone loss
declining within around 3 y after menopause [38]. In general it
appears that bone mineral density may be reduced in women with
early versus late menopause only in the years immediately
following menopause [39,40], but that any difference diminishes
with increasing age and is nonexistent or small after the age of
65 y [3,7,41–43]. Our findings on the incidence of hip fracture in
relation to menopause are generally in line with the observed
effects of menopause on bone mineral density, as we found about a
2-fold difference in hip fracture incidence between premenopausal
and postmenopausal women aged 50–54 y (and there are large
differences in bone mineral density between such women), but
little or no effect of age at menopause on hip fracture risk in
postmenopausal women (and age at menopause appears to have
only a weak effect, if any, on long-term bone mineral density in
postmenopausal women).
Virtually all hip fractures lead to hospitalisation and occurrences
of a first hip fracture in a defined time period are captured well
using NHS hospital admission data [44]. Furthermore, the limited
data available indicate a relatively high level of accuracy of ICD
coding of hip fractures or related diagnoses from hospital
discharge data [45–47]. All participants are registered with the
NHS and were recruited from NHS screening services. Users of
such services are likely to use other NHS health services, including
NHS hospitals. Use of private hospitals in the UK is limited [48],
and many of these admissions are also included in the NHS
hospital admission data. Ascertainment of hip fractures occurring
in Million Women Study participants using routine NHS hospital
data should therefore be virtually complete.
This study has a number of strengths. It is the only study to date,
to our knowledge, to combine prospectively gathered data on
menopause, including data on premenopausal and perimenopausal
Table 3. Hip fracture incidence and RR of hip fracture among postmenopausal women who have never used hormone
replacement therapy, by age and age at menopause.
Age at
Menopause (y) Hip Fracture Rate per 100 Women over 5 y [n] RRa RRb (95% CI)
50–54 Age
Group (y)
55–59 Age
Group (y)
60–64 Age
Group (y)
65–69 Age
Group (y)
70–74 Age
Group (y)
,45 0.15 [9] 0.24 [35] 0.39 [82] 0.63 [101] 1.04 [24] 1.52 1.22 (1.05–1.40)
45–49 0.13 [35] 0.18 [79] 0.33 [152] 0.47 [153] 0.96 [45] 1.23 1.08 (0.97–1.22)
50+ 0.08 [17] 0.13 [124] 0.26 [281] 0.43 [319] 0.72 [77] 1.00 1.00
Total 0.11 [61] 0.15 [238] 0.29 [515] 0.47 [573] 0.82 [146] — —
aAdjusted for age and region only.
bAdjusted for age, region, socioeconomic status, body-mass index, cigarette smoking, alcohol consumption, physical activity, oral contraceptive use, parity, and medical
history.
doi:10.1371/journal.pmed.1000181.t003
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women, with complete follow-up for incident hip fractures and
adjustment for a wide range of potential confounding factors,
including smoking, parity, and comorbidity. Analyses were
restricted to women who had never used hormone replacement
therapy, to avoid biases resulting from the close relationships
between hormone replacement therapy, menopausal status [25],
age at menopause [25], and hip fracture [26]. Since serummeasures
relating to menopausal status, such as serum follicle-stimulating
hormone, were not available for study participants, classification of
menopausal status relied on self-reported information. Women were
considered perimenopausal if they reported irregular menses
attributed to menopause, which means that a proportion of women
who had regular periods right up until menopause will have been
classified as premenopausal during this time. However, the follow-
up data on perimenopausal women indicate that such misclassifi-
cation is likely to be minimal. The inclusion of a small number of
perimenopausal women in with premenopausal women may have
diluted the effect of menopausal status on hip fracture, yielding
more conservative results. Data on other aspects of menopause and
potential confounding factors in this study are also self reported.
Since all exposure data are prospective, any misclassification should
not be biased by the outcome but would tend to dilute the
magnitude of any effect. Although Million Women Study
participants have been shown to be similar to the general population
[49], they are sampled from women attending breast cancer
screening in the UK and this should be borne in mind when
interpreting study results. While some subgroup comparisons had
small numbers of events in each category (Table 3), this is still one of
the largest prospective studies to investigate this issue.
What are the clinical implications of these findings? The findings
suggest that reduced estrogen around the time of menopause leads
to decreased bone mineral density, which in turn increases the risk
of hip fracture, relative to premenopausal women. However, hip
fracture is rare at the age when most women go through the
menopause and increases about 7-fold from age 50–54 to age 70–
74. Our findings show that age is far more important than factors
relating to menopause in determining the risk of hip fracture.
Hence, clinical decisions around hip fracture prevention should be
based on age, and age-related factors, such as frailty, low body-
mass-index, sensory impairment, and comorbidity, rather than on
age at menopause. Factors which increase the risk of falling are
particularly important [50]. The evidence suggests that, later in life,
women with an early menopause can be reassured that their risk of
hip fracture does not differ markedly from that of comparable peers
experiencing a later menopause.
Hip fracture becomes an important health issue as women age
and is a significant cause of morbidity and mortality from around
the age of 70 y onwards—almost one in every 100 never-users of
hormone replacement therapy aged 70–74 y in this cohort were
admitted to hospital with a hip fracture over a 5-y period; whereas
the figure is about seven times lower in women aged 50–54 y. Our
findings show that at around the time of menopause, when hip
fractures are relatively uncommon, postmenopausal women have
a higher incidence of such fractures than premenopausal women.
However, after the menopause the incidence of hip fracture
increases rapidly with age and fracture rates are determined far
more by women’s actual ages than by factors relating to the
menopause, including the type of menopause and women’s ages at
menopause.
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Editors’ Summary
Background. Anyone can break a hip but most hip
fractures occur in elderly people. As people age, their
bones gradually lose minerals and become less dense, which
weakens the bones and makes them more susceptible to
fracture. Because women lose bone density faster than men
as they age and because women constitute the majority of
the elderly, three-quarters of hip fractures occur in women.
Hip fractures can cause long-term health problems and
premature death. Thus, although surgical repair of a broken
hip usually only requires a hospital stay of about a week, a
quarter of elderly people who were living independently
before their fracture have to stay in a nursing home for at
least a year after their injury and a fifth of elderly people who
break a hip die within the year. Most hip fractures are caused
by falls. Regular exercise to improve strength and balance
combined with review of medicines (to reduce side effects
and interactions), regular eye examinations, and the removal
of fall hazards from the home can help to prevent hip
fractures in elderly people.
Why Was This Study Done? Bone density decreases very
rapidly in women immediately after menopause—the time
when menstruation permanently stops—and then continues
to decrease more slowly with age. Most women have their
menopause in their early 50s but menopause can occur in
younger women. Early menopause is thought to be a risk
factor for osteoporosis (thinning of the bones) and fractures
later in life but little is known about how menopause
influences hip fracture risk as women age. In this prospective
study (a type of study in which a group of people is followed
for several years to see whether they develop a particular
condition), the researchers investigate the incidence of hip
fractures in relation to age, menopausal status, and age at
menopause among the participants of the Million Women
Study. This study, which recruited 1.3 million women aged
50–64 years who attended UK breast cancer screening clinics
between 1996 and 2001, has been investigating how
reproductive and lifestyle factors affect women’s health.
What Did the Researchers Do and Find? At enrollment
and three years later, the study participants provided
information about their menopausal status and other
health and lifestyle factors likely to affect their fracture risk.
From these data, the researchers identified more than half a
million women who had never used hormone replacement
therapy (which reduces fracture risk) and who had given
complete information about their menopausal status. They
then looked for statistical associations between the
occurrence of a first hip fracture in these women over the
next few years and their age, menopausal status, and age at
menopause. Among women aged 50–54 years, postmeno-
pausal women were twice as likely to have a hip fracture as
premenopausal women. Among postmenopausal women,
the incidence of hip fractures increased steeply with age and
was seven times higher in 70–74-year olds than in 50–54-
year olds. Women who had their menopause before age 45
had a slightly increased risk of hip fracture but any effect of
age at menopause on the risk of hip fracture was small
compared to the effect of age itself, and the slightly
increased risk may have been due to other factors that
could not be fully accounted for in the analysis.
What Do These Findings Mean? These findings indicate
that around the time of menopause, although hip fractures
are rare, the risk of a fracture in postmenopausal women is
twice that in premenopausal women. The findings also show
that among postmenopausal women, age is the major
determinant of hip fracture risk and that for women of a
given age, their age at menopause has little effect on hip
fracture risk. Women attending breast cancer screening clinics
and completing questionnaires about their health may not be
representative of the general population. Furthermore, these
findings rely on women self-reporting their menopausal status
accurately. Nevertheless, the results of this study suggest that
clinicians advising women about hip fracture prevention
should probably base their advice on the woman’s age and on
age-related factors such as frailty rather than on factors
related to menopause. Clinicians can also now reassure elderly
women who had an early menopause that their risk of hip
fracture is unlikely to be higher than that of similar women
who had a later menopause.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000181.
N The American Academy of Orthopaedic Surgeons has
detailed information about hip fractures
N The US National Institute of Arthritis and Muscoloskeletal
and Skin Diseases has an interactive feature called ‘‘Check
up on your bones’’ and provides detailed information
about osteoporosis, including advice on fall prevention
N The US Centers for Disease Control and Prevention has a
fact sheet about hip fractures among older adults
N MedlinePlus has links to resources about hip fracture,
osteoporosis, and menopause (in English and Spanish)
N More information on the Million Women Study is available
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